PENGAMBILAN KEPUTUSAN KOMPONEN DARAH DALAM PENGENDALIAN PERSEDIAAN DENGAN MENGGUNAKAN METODE AHP DI PMI KOTA BANDUNG

Authors

  • Muchammad Fauzi Universitas Widyatama
  • Senator Nur Bahagia technology institute of bandung

DOI:

https://doi.org/10.33197/jitter.vol5.iss2.2019.276

Keywords:

Overstock, waste, blood component, AHP

Abstract

PMI of Bandung City experienced overstock. Overstock and expired blood supplies must be destroyed. In the overstock phase every month, PMI of Bandung City experiences waste and needs to be controlled inventory. In the blood have six components that need to be controlled, but it takes a long time to analyze each component of the bloood. It is necessary to determine the priority blood components that must bee controlled immediately so that they are expected to influence the reduction in the destroyed cost. The purpose of this study is find out what blood component are prioritized to control their supply. Determination of blood component priority using the AHP (Analitycal Hierarchy Process) approach. The AHP method is decision making model that breaks down complex multi-criteria problems into a hierarchy. The priority blood component to be controlled is Packed Red Cell (PRC) component of 0.338. This value is obtained because it is influenced by the weight of the supply criteria of 0.709, demand of 0.113; and lifetime of 0.179.

Downloads

Download data is not yet available.

Downloads

Published

2019-10-11

How to Cite

[1]
M. Fauzi and S. N. Bahagia, “PENGAMBILAN KEPUTUSAN KOMPONEN DARAH DALAM PENGENDALIAN PERSEDIAAN DENGAN MENGGUNAKAN METODE AHP DI PMI KOTA BANDUNG”, JITTER, vol. 5, no. 2, pp. 13–20, Oct. 2019.

Issue

Vol. 5 No. 2 (2019)

Section

Articles

License

Submission of a manuscript implies that the submitted work has not been published before (except as part of a thesis or report, or abstract); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors. If and when the manuscript is accepted for publication, the author(s) still hold the copyright and retain publishing rights without restrictions. Authors or others are allowed to multiply the article as long as not for commercial purposes. For the new invention, authors are suggested to manage its patent before published. The license type is CC-BY-SA 4.0.